Table 2. Association between the patient's clinicopathological characteristics and CD73 expression in 162 HNSCC patients.
| Clinicopathological features | No. | CD73 | expression | X2 | P |
|---|---|---|---|---|---|
| Negative (%) | Positive (%) | ||||
| Gender | 0.981 | 0.277 | |||
| Male | 100 | 35 (35.0%) | 65 (65.0%) | ||
| Female | 62 | 27 (43.5%) | 35 (56.5%) | ||
| Age, years | 0.768 | 0.238 | |||
| < 60 | 87 | 36 (41.4%) | 51 (58.6%) | ||
| ≥ 60 | 75 | 26 (34.7%) | 49 (65.3%) | ||
| Smoking | 0.282 | 0.360 | |||
| Yes | 59 | 21 (35.6%) | 38 (64.4%) | ||
| No | 103 | 41 (39.8%) | 62 (60.2%) | ||
| Drinking | 0.872 | 0.226 | |||
| Yes | 46 | 15 (32.6%) | 31 (67.4%) | ||
| No | 116 | 47 (40.5%) | 69 (59.5%) | ||
| Tumor stage | 3.453 | 0.056 | |||
| 3–4 | 33 | 8 (24.2%) | 25 (75.8%) | ||
| 1–2 | 129 | 54 (41.9%) | 75 (58.1%) | ||
| Clinical stage | 4.753 | 0.021 | |||
| 3–4 | 67 | 19 (28.4%) | 48 (71.6%) | ||
| 1–2 | 95 | 43 (45.3%) | 52 (54.7%) | ||
| Lymph node metastasis | 4.175 | 0.000 | |||
| + | 52 | 10 (19.2%) | 42 (80.8%) | ||
| − | 110 | 52 (47.3%) | 58 (52.7%) | ||
| Histological type | 0.136 | 0.460 | |||
| Poor | 14 | 6 (42.9%) | 8 (57.1%) | ||
| Well- Moderate | 148 | 56 (37.8%) | 92 (62.2%) |